Close Menu

Technologist I / II

Organization
WuXi NextCODE
Job Location
2 Gill Street
Suite F
Woburn, MA 01801
United States
Job Description

We are seeking a highly motivated and enthusiastic Technologist I / II to develop, optimize, and perform next-generation sequencing (NGS) assays in our CLIA/CAP laboratory in Woburn, MA.

ESSENTIAL FUNCTIONS

Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions.

  • Perform laboratory functions in accordance with standard operating procedures
  • Extract nucleic acids from various specimens including cell lines, human blood, fresh frozen tissue and Formalin-Fixed Paraffin Embedded tumor specimens)
  • Participate in regular Proficiency Testing
  • Prepare auditing documents
  • Collaborate with the lab manager on all activities
  • Utilize an array of instrumentation, including Covaris sonicator, Agilent Bioanalyzer and TapeStation, ThermoFisher Qubit, and Illumina sequencers
  • Execute next-generation sequencing (NGS)-based workflows including exome and transcriptome sequencing*
  • Maintain batch record reports, consumable inventory, equipment, and calibration to comply with CLIA/CAP requirements*
  • Implement a laboratory data management system, including sample accessioning and management*
  • Utilize automation liquid handling systems to prepare NGS libraries*

*Denotes additional job responsibilities of a Technologist II.

Requirements

REQUIRED EDUCATION AND EXPERIENCE

  • Bachelor's degree with a major in Molecular Biology or related field
  • Minimum of 1 year of experience using NGS technology
  • Excellent communication skills (written and verbal)
  • Ability to complete tasks in a timely manner

PREFERRED EDUCATION AND EXPERIENCE

  • Master's degree in Molecular Biology or related field a plus
  • Experience with lab automation
  • Experience in a CLIA/CAP laboratory
  • Experience with QA
About Our Organization

Biopharma companies are challenged with turning advancements in genomics into better therapies and improved health.  By providing sequencing services and custom cohorts of deeply phenotyped and genotyped patients, as well as the GORdb platform and analysis suite and cutting-edge AI, we enable our clients to accelerate their drug discovery and development programs.

A new study finds that a positive lab environment can encourage undergraduates to continue to perform research.

A new analysis suggests non-US citizen STEM PhDs might pass up jobs at US-based startups due to visa concerns.

A UK survey of researchers who identified as LGBT+ and allies uncovered evidence of unwelcoming workplace climates in the physical sciences.

At the Guardian, the University of Edinburgh's Nikolay Ogryzko argues that universities need to better invest in postdocs' careers.